In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

Early results from a new study suggest that a simple saliva test and powerful artificial intelligence algorithms could help ...

A Phase 2 study evaluating TPST-1495 in patients with FAP is set to begin this year, conducted by the Cancer Prevention Clinical Trials Network and funded by the National Cancer Institute (NCI) ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

Jazz Pharmaceuticals JAZZ and Harmony Biosciences HRMY have emerged as notable players in the neuroscience space, especially in the sleep disorder segment. Jazz Pharmaceuticals markets multiple ...

Significant weight gain is a common side effect of many psychiatric medications. Fortunately, there are options for those who ...

From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

Cancer drugs conferring low or no therapeutic benefits accounted for $6.7 billion in post-rebate Medicare spending in 2022.

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

This treatment combines an antibody that targets cancer cells with a chemotherapy drug, delivering the latter directly to the tumour while sparing healthy tissue. It has significantly improved ...

Vemurafenib (Zelboraf) can be given as a single-drug treatment. MET gene defect. This non-inherited gene defect can cause something referred to as MET (mesenchymal-epithelial transition ...